Now, just over four months after the publication of the amending regulation to the MDR, which brought extended compliance timelines for legacy products, the real benefits and outstanding issues are really beginning to be understood.
Notably, during July, the European Commission published a survey showing the number of certificates granted by and applications made to EU notified bodies designated under the MDR and IVDR. It...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?